Sanjiv Kaul
Healthcare
ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drugmaker, two ......
Finance
ChrysCapital targets large corpus as it floats eighth sector-agnostic fund
Homegrown private equity firm ChrysCapital has floated its eighth sector-agnostic fund with a target corpus marginally higher than initially planned, ......
Finance
ChrysCapital checks out of PIPE portfolio firm with high returns
Homegrown private equity firm ChrysCapital has fully exited a company it had backed less than four years ago in its ......
Healthcare
How ChrysCap appeared out of nowhere and inked deal to reinvest in Mankind Pharma
It seems straight out of a Hollywood romcom. A couple breaks up, although on good terms. Three years later, the ......
Finance
ChrysCap sets up dedicated portfolio value creation team
Homegrown private equity firm ChrysCapital, which recently strengthened its leadership team by hiring Sudip Nandy from Aricent Group and Prashant ......
Healthcare
Top PE firms eye ChrysCapital's stake in Intas Pharma
Several private equity investors are in the fray for PE firm ChrysCapital Investment Advisors Pvt. Ltd’s stake in Intas Pharmaceuticals ......
Healthcare
ChrysCapital logs partial exit from PIPE portfolio with handsome returns
ChrysCapital Investment Advisors India Pvt Ltd, which is in the process of raising its new fund, has offloaded more stake ......
TMT
ChrysCapital part exits IT firm Cyient with 3x
Private equity firm ChrysCapital has part-exited Hyderabad-based IT company Cyient Ltd (formerly Infotech Enterprises), scoring around 3x returns on its ......